DT
HealthMore in Health→
New Framework Selects Immune Aging Biomarkers for Clinical Trials
Key Takeaways
- Researchers propose a standardized framework for selecting immune aging biomarkers in clinical trials.
- Key criteria include association with age-related outcomes, responsiveness to interventions, and feasibility.
- Candidate biomarkers include naive T cells, inflammatory cytokines, telomere length, and CMV-related markers.
- The framework aims to accelerate geroscience trials and improve comparability across studies.
DE
DT Editorial Team··via nature.com